Cargando…

Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025

Colorectal cancer (CRC) has emerged as a major public health concern in China during the last decade. In this study, we investigated the disease burden posed by CRC and analyzed temporal trends in CRC incidence and mortality rates in this country. We collected CRC incidence data from the Cancer Inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Cao, Fei, Zhang, Guoyao, Shi, Lei, Chen, Suhua, Zhang, Zhihui, Zhi, Weiguo, Ma, Tianjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393365/
https://www.ncbi.nlm.nih.gov/pubmed/30847304
http://dx.doi.org/10.3389/fonc.2019.00098
_version_ 1783398672553213952
author Zhang, Lei
Cao, Fei
Zhang, Guoyao
Shi, Lei
Chen, Suhua
Zhang, Zhihui
Zhi, Weiguo
Ma, Tianjiang
author_facet Zhang, Lei
Cao, Fei
Zhang, Guoyao
Shi, Lei
Chen, Suhua
Zhang, Zhihui
Zhi, Weiguo
Ma, Tianjiang
author_sort Zhang, Lei
collection PubMed
description Colorectal cancer (CRC) has emerged as a major public health concern in China during the last decade. In this study, we investigated the disease burden posed by CRC and analyzed temporal trends in CRC incidence and mortality rates in this country. We collected CRC incidence data from the Cancer Incidence in Five Continents, Volume XI dataset and the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of CRC by sex and age, from the 2016 Global Burden of Diseases Study. We used the average annual percentage change (AAPC) to quantify temporal trends in CRC incidence and mortality from 1990 to 2016 and found the ASIR of CRC increased from 14.25 per 100,000 in 1990 to 25.27 per 100,000 in 2016 (AAPC = 2.34, 95% confidence interval [CI] 2.29, 2.39). Cancer cases increased from 104.3 thousand to 392.8 thousand during the same period. The ASIR increased by 2.76% (95% CI 2.66%, 2.85%) and 1.70% (95% CI 1.64%, 1.76%) per year in males and females, respectively. The highest AAPC was found in people aged 15–49 years (2.76, 95% CI 2.59, 2.94). Cancer deaths increased from 81.1 thousand in 1990 to 167.1 thousand in 2016, while the ASMR remained stable (−0.04, 95% CI −0.13, 0.05), A mild increase (AAPC = 0.42, 95% CI 0.34, 0.51) was found among males and a significant decrease (AAPC = −0.75, 95% CI −0.90, −0.60) was found among females. Between 2016 and 2025, cancer cases and deaths are expected to increase from 392.8 and 167.1 thousand in 2016 to 642.3 (95% CI 498.4, 732.1) and 221.1 thousand (95% CI 122.5, 314.8) in 2025, respectively. Our study showed a steady increase in the CRC incidence in China over the past three decades and predicted a further increase in the near future. To combat this health concern, the prevention and management of known risk factors should be promoted through national polices. Greater priority should be given to CRC prevention in younger adults, and CRC screening should be widely adopted for this population.
format Online
Article
Text
id pubmed-6393365
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63933652019-03-07 Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025 Zhang, Lei Cao, Fei Zhang, Guoyao Shi, Lei Chen, Suhua Zhang, Zhihui Zhi, Weiguo Ma, Tianjiang Front Oncol Oncology Colorectal cancer (CRC) has emerged as a major public health concern in China during the last decade. In this study, we investigated the disease burden posed by CRC and analyzed temporal trends in CRC incidence and mortality rates in this country. We collected CRC incidence data from the Cancer Incidence in Five Continents, Volume XI dataset and the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of CRC by sex and age, from the 2016 Global Burden of Diseases Study. We used the average annual percentage change (AAPC) to quantify temporal trends in CRC incidence and mortality from 1990 to 2016 and found the ASIR of CRC increased from 14.25 per 100,000 in 1990 to 25.27 per 100,000 in 2016 (AAPC = 2.34, 95% confidence interval [CI] 2.29, 2.39). Cancer cases increased from 104.3 thousand to 392.8 thousand during the same period. The ASIR increased by 2.76% (95% CI 2.66%, 2.85%) and 1.70% (95% CI 1.64%, 1.76%) per year in males and females, respectively. The highest AAPC was found in people aged 15–49 years (2.76, 95% CI 2.59, 2.94). Cancer deaths increased from 81.1 thousand in 1990 to 167.1 thousand in 2016, while the ASMR remained stable (−0.04, 95% CI −0.13, 0.05), A mild increase (AAPC = 0.42, 95% CI 0.34, 0.51) was found among males and a significant decrease (AAPC = −0.75, 95% CI −0.90, −0.60) was found among females. Between 2016 and 2025, cancer cases and deaths are expected to increase from 392.8 and 167.1 thousand in 2016 to 642.3 (95% CI 498.4, 732.1) and 221.1 thousand (95% CI 122.5, 314.8) in 2025, respectively. Our study showed a steady increase in the CRC incidence in China over the past three decades and predicted a further increase in the near future. To combat this health concern, the prevention and management of known risk factors should be promoted through national polices. Greater priority should be given to CRC prevention in younger adults, and CRC screening should be widely adopted for this population. Frontiers Media S.A. 2019-02-21 /pmc/articles/PMC6393365/ /pubmed/30847304 http://dx.doi.org/10.3389/fonc.2019.00098 Text en Copyright © 2019 Zhang, Cao, Zhang, Shi, Chen, Zhang, Zhi and Ma. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Lei
Cao, Fei
Zhang, Guoyao
Shi, Lei
Chen, Suhua
Zhang, Zhihui
Zhi, Weiguo
Ma, Tianjiang
Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025
title Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025
title_full Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025
title_fullStr Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025
title_full_unstemmed Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025
title_short Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025
title_sort trends in and predictions of colorectal cancer incidence and mortality in china from 1990 to 2025
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393365/
https://www.ncbi.nlm.nih.gov/pubmed/30847304
http://dx.doi.org/10.3389/fonc.2019.00098
work_keys_str_mv AT zhanglei trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT caofei trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT zhangguoyao trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT shilei trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT chensuhua trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT zhangzhihui trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT zhiweiguo trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025
AT matianjiang trendsinandpredictionsofcolorectalcancerincidenceandmortalityinchinafrom1990to2025